Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2007.090027v1, 2007; 10.1373/clinchem.2007.090027
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.090027v1
53/9/1694    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dodder, N. G.
Right arrow Articles by Welch, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dodder, N. G.
Right arrow Articles by Welch, M. J.

Received on April 6, 2007
Accepted on July 3, 2007

General Clinical Chemistry

Certification of Creatinine in a Human Serum Reference Material by GC-MS and LC-MS

Nathan G. Dodder 1*, Susan S.-C. Tai 1, Lorna T. Sniegoski 1, Nien F. Zhang 2, Michael J. Welch 1

1 Analytical Chemistry Division, National Institute of Standards and Technology, Gaithersburg, MD
2 Department of Statistical Engineering Division, National Institute of Standards and Technology, Gaithersburg, MD

* To whom correspondence should be addressed. E-mail: nathan.dodder{at}nist.gov.

Background: To meet recommendations given by the Laboratory Working Group of the National Kidney Disease Education Program (NKDEP) for improving serum creatinine measurements, NIST developed standard reference material (SRM) 967 Creatinine in Frozen Human Serum. SRM 967 is intended for use by laboratories and in vitro diagnostic equipment manufacturers for the calibration and evaluation of routine clinical methods.

Methods: The SRM was produced from 2 serum pools with different creatinine concentrations. The concentrations were certified using a higher-order isotope-dilution GC-MS method and an isotope-dilution LC-MS method. The LC-MS method is a potential higher-order reference measurement procedure.

Results: The GC-MS mean (CV) concentrations were 67.0 (0.9%) µmol/L for serum pool 1 and 346.1 (0.45%) µmol/L for serum pool 2. The LC-MS results were 66.1 (0.2%) µmol/L and 346.3 (0.2%) µmol/L, respectively. For serum pool 1, there was a 1.4% difference between the mean GC-MS and LC-MS measurements, and a 0.10% difference for serum pool 2. The results from the 2 methods were combined to give the certified concentrations and expanded uncertainties.

Conclusions: The certified concentration (expanded uncertainty) of SRM 967 was 66.5 (1.8) µmol/L for serum pool 1 (a value close to the diagnostically important concentration of 88.4 µmol/L) and 346.2 (7.4) µmol/L for serum pool 2 (a concentration corresponding to that expected in a patient with chronic kidney disease).




The following articles in journals at HighWire Press have cited this article:


Home page
Nephrol Dial TransplantHome page
J. R. Delanghe
How to estimate GFR in children
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 714 - 716.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.